At close: December 20 at 4:00:03 PM EST
After hours: December 20 at 7:59:19 PM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| CHAN IAN Chief Executive Officer | Stock Award(Grant) | Nov 13, 2024 | -- |
| DOVE BRYAN Director | Conversion of Exercise of derivative security | Apr 18, 2023 | 50,000 |
| KAHLON IQBALJIT Director | Conversion of Exercise of derivative security | Apr 18, 2023 | 50,000 |
| LORD JOANNA Director | Conversion of Exercise of derivative security | Apr 18, 2023 | 50,000 |
| SCHIANO DOMINICK J. Director | Conversion of Exercise of derivative security | Apr 18, 2023 | 50,000 |
| STANWOOD DARREN Director | Conversion of Exercise of derivative security | Apr 18, 2023 | 50,000 |
| SUK JIN WOOK Chief Executive Officer | Stock Award(Grant) | Nov 13, 2024 | 91,900 |
Related Tickers
SLXN Silexion Therapeutics Corp
2.4400
+0.83%
APTO Aptose Biosciences Inc.
0.2790
+63.92%
PBM Psyence Biomedical Ltd.
3.1800
+29.27%
ELAB Elevai Labs Inc.
2.5600
+8.94%
AADI Aadi Bioscience, Inc.
3.3900
+46.12%
BPTH Bio-Path Holdings, Inc.
1.2600
-15.44%
PHIO Phio Pharmaceuticals Corp.
1.7600
+1.15%
OGEN Oragenics, Inc.
0.3552
-5.53%
XLO Xilio Therapeutics, Inc.
1.2800
+36.46%
TCBP TC Biopharm (Holdings) Plc
0.6600
+0.15%